Pharmacotherapy of borderline personality disorder

被引:0
|
作者
Hirschfeld, RMA [1 ]
机构
[1] Univ Texas, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77555 USA
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 50 条
  • [21] Pharmacotherapy for borderline personality disorder: A review of the literature and recommendations for treatment
    Dimeff, LA
    McDavid, J
    Linehan, MM
    JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 1999, 6 (01) : 113 - 138
  • [22] CONTINUATION PHARMACOTHERAPY OF BORDERLINE PERSONALITY-DISORDER WITH HALOPERIDOL AND PHENELZINE
    CORNELIUS, JR
    SOLOFF, PH
    PEREL, JM
    ULRICH, RF
    AMERICAN JOURNAL OF PSYCHIATRY, 1993, 150 (12): : 1843 - 1848
  • [23] THE ROLE OF PHARMACOTHERAPY IN THE TREATMENT OF PATIENTS WITH BORDERLINE PERSONALITY-DISORDER
    STONE, MH
    PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (04) : 564 - 571
  • [24] Hospitalization and pharmacotherapy for borderline personality disorder in a psychiatric emergency service
    Pascual, Juan C.
    Corcoles, David
    Castano, Juan
    Gines, Jose M.
    Gurrea, Alfredo
    Martin-Santos, Rocio
    Garcia-Ribera, Carlos
    Perez, Victor
    Bulbena, Antonio
    PSYCHIATRIC SERVICES, 2007, 58 (09) : 1199 - 1204
  • [25] Pharmacotherapy for Borderline Personality Disorder: A Review of the Literature and Recommendations for Treatment
    Linda A. Dimeff
    Joshua McDavid
    Marsha M. Linehan
    Journal of Clinical Psychology in Medical Settings, 1999, 6 : 113 - 138
  • [26] Pharmacotherapy of the Borderline-Personality disorder:: A metaanalysis randomized controlled trials
    Stoffers, Jutta
    Voellm, B.
    Ruecker, G.
    Antes, G.
    Dennis, J.
    Jacob, G. A.
    Lieb, K.
    NERVENARZT, 2007, 78 : 198 - 198
  • [27] Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
    Bozzatello, Paola
    Rocca, Paola
    De Rosa, Maria Laura
    Bellino, Silvio
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) : 47 - 61
  • [28] Pharmacotherapy for Borderline Personality Disorder-Current Evidence and Recent Trends
    Stoffers, Jutta M.
    Lieb, Klaus
    CURRENT PSYCHIATRY REPORTS, 2015, 17 (01)
  • [29] Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
    Lieb, Klaus
    Voellm, Birgit
    Ruecker, Gerta
    Timmer, Antje
    Stoffers, Jutta M.
    BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (01) : 4 - 12
  • [30] PHARMACOTHERAPY OF BORDERLINE PERSONALITY-DISORDER - ALPRAZOLAM, CARBAMAZEPINE, TRIFLUOPERAZINE, AND TRANYLCYPROMINE
    COWDRY, RW
    GARDNER, DL
    ARCHIVES OF GENERAL PSYCHIATRY, 1988, 45 (02) : 111 - 119